All Stories

  1. Extended Heterosubtypic Neutralization and Preclinical Model In Vivo Protection from Clade 2.3.4.4b H5 Influenza Virus Infection by Broadly Neutralizing Antibodies

    Article • Vaccines, January 2026, MDPI AG

    PhD Giuseppe Andrea Sautto

  2. Novel Skp1 inhibitor has potent preclinical efficacy against castration-resistant prostate cancer

    Article • British Journal of Cancer, April 2025, Springer Science + Business Media

    PhD Giuseppe Andrea Sautto

  3. Towards an HCV vaccine: an overview of the immunization strategies for eliciting an effective B-cell response

    Article • Expert Review of Vaccines, January 2025, Taylor & Francis

    PhD Giuseppe Andrea Sautto

  4. Exploring T-Cell Immunity to Hepatitis C Virus: Insights from Different Vaccine and Antigen Presentation Strategies

    Article • Vaccines, August 2024, MDPI AG

    PhD Giuseppe Andrea Sautto

  5. Prior SARS-CoV-2 Infection Enhances Initial mRNA Vaccine Response with a Lower Impact on Long-Term Immunity

    Article • ImmunoHorizons, October 2023, Oxford University Press (OUP)

    PhD Giuseppe Andrea Sautto

  6. Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine

    Article • Communications Biology, April 2023, Springer Science + Business Media

    PhD Giuseppe Andrea Sautto

  7. The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines

    Article • The Journal of Immunology, July 2022, Oxford University Press (OUP)

    PhD Giuseppe Andrea Sautto

  8. The Effect of Waning on Antibody Levels and Memory B Cell Recall following SARS-CoV-2 Infection or Vaccination

    Article • Vaccines, April 2022, MDPI AG

    PhD Giuseppe Andrea Sautto

  9. New Insights into Immune-Based Diagnosis, Therapy and Prophylaxis for Infectious Diseases 2020

    Article • Journal of Immunology Research, December 2021, Wiley

    PhD Giuseppe Andrea Sautto

  10. A Competitive Hemagglutination Inhibition Assay for Dissecting Functional Antibody Activity against Influenza Virus

    Article • Journal of Virology, November 2021, ASM Journals

    PhD Giuseppe Andrea Sautto

  11. Impaired memory B-cell recall responses in the elderly following recurrent influenza vaccination

    Article • PLOS One, August 2021, PLOS

    Dr Ted M Ross, PhD Giuseppe Andrea Sautto

  12. Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays

    Article • Cells, July 2021, MDPI AG

    PhD Giuseppe Andrea Sautto

  13. Dual oxidase 1 promotes antiviral innate immunity

    Article • Proceedings of the National Academy of Sciences, June 2021, Proceedings of the National Academy of Sciences

    PhD Giuseppe Andrea Sautto

  14. An H1N1 Computationally Optimized Broadly Reactive Antigen Elicits a Neutralizing Antibody Response against an Emerging Human-Infecting Eurasian Avian-Like Swine Influenza Virus

    Article • Journal of Virology, June 2021, ASM Journals

    PhD Giuseppe Andrea Sautto

  15. Affinity tag coating enables reliable detection of antigen-specific B cells in ImmunoSpot assays

    Article • June 2021, Cold Spring Harbor Laboratory Press

    PhD Giuseppe Andrea Sautto

  16. Feline Morbillivirus Infection in Domestic Cats: What Have We Learned So Far?

    Article • Viruses, April 2021, MDPI AG

    PhD Giuseppe Andrea Sautto

  17. Convergent antibody evolution and clonotype expansion following influenza virus vaccination

    Article • PLOS One, February 2021, PLOS

    Dr Ted M Ross, PhD Giuseppe Andrea Sautto

  18. Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer

    Article • Theranostics, January 2021, Ivyspring International Publisher

    PhD Giuseppe Andrea Sautto

  19. High-Yield Expression and Purification of Recombinant Influenza Virus Proteins from Stably-Transfected Mammalian Cell Lines

    Article • Vaccines, August 2020, MDPI AG

    PhD Giuseppe Andrea Sautto

  20. An Influenza Virus Hemagglutinin Computationally Optimized Broadly Reactive Antigen Elicits Antibodies Endowed with Group 1 Heterosubtypic Breadth against Swine Influenza Viruses

    Article • Journal of Virology, January 2020, ASM Journals

    PhD Giuseppe Andrea Sautto

  21. A Computationally Optimized Broadly Reactive Antigen Subtype–Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin

    Article • The Journal of Immunology, December 2019, The American Association of Immunologists

    PhD Giuseppe Andrea Sautto

  22. Pre-existing subtype immunodominance shapes memory B cell recall response to influenza vaccination

    Article • JCI Insight, December 2019, American Society for Clinical Investigation

    PhD Giuseppe Andrea Sautto

  23. Next Generation Vaccines for Infectious Diseases

    Article • Journal of Immunology Research, April 2019, Hindawi Publishing Corporation

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  24. Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines

    Article • Journal of Immunology Research, March 2019, Hindawi Publishing Corporation

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  25. Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin Antigens

    Article • ImmunoHorizons, August 2018, The American Association of Immunologists

    PhD Giuseppe Andrea Sautto

  26. Infection of Ferrets with Influenza Virus Elicits a Light Chain–Biased Antibody Response against Hemagglutinin

    Article • The Journal of Immunology, October 2017, The American Association of Immunologists

    PhD Giuseppe Andrea Sautto

  27. Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge

    Article • Antiviral Research, July 2017, Elsevier

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  28. A Biologically-validated HCV E1E2 Heterodimer Structural Model

    Article • Scientific Reports, March 2017, Springer Science + Business Media

    PhD Giuseppe Andrea Sautto

  29. Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study

    Article • Autoimmunity Reviews, March 2017, Elsevier

    PhD Giuseppe Andrea Sautto

  30. New Insights for Immune-Based Diagnosis and Therapy for Infectious Diseases

    Article • Journal of Immunology Research, January 2017, Hindawi Publishing Corporation

    PhD Giuseppe Andrea Sautto

  31. Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?

    Article • Clinical Microbiology and Infection, August 2015, Elsevier

    PhD Giuseppe Andrea Sautto

  32. Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections

    Article • Future Microbiology, April 2015, Future Medicine

    PhD Giuseppe Andrea Sautto

  33. Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein

    Article • Gut, February 2015, BMJ

    PhD Giuseppe Andrea Sautto

  34. HCV E2 core structures and mAbs: something is still missing

    Article • Drug Discovery Today, December 2014, Elsevier

    PhD Giuseppe Andrea Sautto

  35. Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy

    Article • Antiviral Research, August 2014, Elsevier

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  36. Possible Future Monoclonal Antibody (mAb)-Based Therapy against Arbovirus Infections

    Article • BioMed Research International, January 2013, Wiley

    Nicasio Mancini, PhD Giuseppe Andrea Sautto

  37. Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies

    Article • Clinical and Developmental Immunology, January 2013, Wiley

    Nicasio Mancini, PhD Giuseppe Andrea Sautto

  38. Peptide-Based Vaccinology: Experimental and Computational Approaches to Target Hypervariable Viruses through the Fine Characterization of Protective Epitopes Recognized by Monoclonal Antibodies and the Identification of T-Cell-Activating Peptides

    Article • Clinical and Developmental Immunology, January 2013, Hindawi Publishing Corporation

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  39. Molecular Signatures of Hepatitis C Virus (HCV)-Induced Type II Mixed Cryoglobulinemia (MCII)

    Article • Viruses, November 2012, MDPI AG

    Nicasio Mancini, PhD Giuseppe Andrea Sautto

  40. Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference

    Article • Antiviral Research, October 2012, Elsevier

    Nicasio Mancini, PhD Giuseppe Andrea Sautto

  41. Neutralization Interfering Antibodies: A “Novel” Example of Humoral Immune Dysfunction Facilitating Viral Escape?

    Article • Viruses, September 2012, MDPI AG

    Nicasio Mancini, PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  42. HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role

    Article • Clinical and Developmental Immunology, January 2012, Wiley

    Nicasio Mancini, PhD Giuseppe Andrea Sautto

  43. Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV)

    Article • Virology, March 2010, Elsevier

    Nicasio Mancini, PhD Giuseppe Andrea Sautto

  44. Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes

    Article • PLOS One, December 2009, PLOS

    Nicasio Mancini, PhD Giuseppe Andrea Sautto